» Articles » PMID: 26998662

Progress and Challenges Associated with the Development of Ricin Toxin Subunit Vaccines

Overview
Date 2016 Mar 22
PMID 26998662
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

The past several years have seen major advances in the development of a safe and efficacious ricin toxin vaccine, including the completion of two Phase I clinical trials with two different recombinant A subunit (RTA)-based vaccines: RiVax™ and RVEc™ adsorbed to aluminum salt adjuvant, as well as a non-human primate study demonstrating that parenteral immunization with RiVax elicits a serum antibody response that was sufficient to protect against a lethal dose aerosolized ricin exposure. One of the major obstacles moving forward is assessing vaccine efficacy in humans, when neither ricin-specific serum IgG endpoint titers nor toxin-neutralizing antibody levels are accepted as definitive predictors of protective immunity. In this review we summarize ongoing efforts to leverage recent advances in our understanding of RTA-antibody interactions at the structural level to develop novel assays to predict vaccine efficacy in humans.

Citing Articles

Serum antibody profiling identifies vaccine-induced correlates of protection against aerosolized ricin toxin in rhesus macaques.

Roy C, Ehrbar D, Van Slyke G, Doering J, Didier P, Doyle-Meyers L NPJ Vaccines. 2022; 7(1):164.

PMID: 36526642 PMC: 9755799. DOI: 10.1038/s41541-022-00582-x.


Durable Immunity to Ricin Toxin Elicited by a Thermostable, Lyophilized Subunit Vaccine.

Novak H, Doering J, Ehrbar D, Donini O, Mantis N mSphere. 2021; 6(6):e0075021.

PMID: 34730377 PMC: 8565519. DOI: 10.1128/mSphere.00750-21.


An Electrochemical Approach to Follow and Evaluate the Kinetic Catalysis of Ricin on hsDNA.

Oliveira G, Schneedorf J Life (Basel). 2021; 11(5).

PMID: 33946642 PMC: 8145570. DOI: 10.3390/life11050405.


A Simple, Fast and Portable Method for Electrochemical Detection of Adenine Released by Ricin Enzymatic Activity.

Oliveira G, Schneedorf J Toxins (Basel). 2021; 13(4).

PMID: 33810228 PMC: 8066795. DOI: 10.3390/toxins13040238.


An intranasally administered monoclonal antibody cocktail abrogates ricin toxin-induced pulmonary tissue damage and inflammation.

Rong Y, Torres-Velez F, Ehrbar D, Doering J, Song R, Mantis N Hum Vaccin Immunother. 2019; 16(4):793-807.

PMID: 31589555 PMC: 7227631. DOI: 10.1080/21645515.2019.1664243.


References
1.
Prigent J, Panigai L, Lamourette P, Sauvaire D, Devilliers K, Plaisance M . Neutralising antibodies against ricin toxin. PLoS One. 2011; 6(5):e20166. PMC: 3102095. DOI: 10.1371/journal.pone.0020166. View

2.
OHara J, Mantis N . Neutralizing monoclonal antibodies against ricin's enzymatic subunit interfere with protein disulfide isomerase-mediated reduction of ricin holotoxin in vitro. J Immunol Methods. 2013; 395(1-2):71-8. PMC: 3753220. DOI: 10.1016/j.jim.2013.06.004. View

3.
Spooner R, Lord J . How ricin and Shiga toxin reach the cytosol of target cells: retrotranslocation from the endoplasmic reticulum. Curr Top Microbiol Immunol. 2011; 357:19-40. DOI: 10.1007/82_2011_154. View

4.
Wilhelmsen C, Pitt M . Lesions of acute inhaled lethal ricin intoxication in rhesus monkeys. Vet Pathol. 1996; 33(3):296-302. DOI: 10.1177/030098589603300306. View

5.
Montfort W, Villafranca J, Monzingo A, Ernst S, Katzin B, Rutenber E . The three-dimensional structure of ricin at 2.8 A. J Biol Chem. 1987; 262(11):5398-403. View